Dear Doctor - Participate in the Survey on fecal microbiota transplantation "Fecal microbiota transplantation (FMT) is a procedure in which stool from a healthy donor is transplanted into the gastrointestinal tract of a person with a gut disorder. The goal of FMT is to restore the composition and function of the gut microbiome.Research on FMT is still in its early stages, but preliminary studies suggest that it may be an effective treatment for a variety of gut disorders, including Clostridium difficile infection (CDI), inflammatory bowel disease (IBD), and irritable bowel syndrome (IBS). In addition, because the gut microbiome plays a role in immunity, there is interest in using FMT as a treatment for autoimmune diseases such as Crohn's disease and type 1 diabetes.Side effects of FMT are generally minor and include abdominal pain, bloating, diarrhea, and constipation. However, serious complications have been reported in rare cases, such as sepsis (a potentially life-threatening condition caused by infection).If you are considering FMT for yourself or a loved one, it is important to speak with a healthcare provider who is experienced in this procedure. Participate in Surveys "
1.
Imfinzi + Imjudo, EU approved for patients with advanced lung cancer and non-small cell lung cancer: AstraZeneca
2.
More Support for Early Detection; Cancer in Men Rising; Diet Drives Colon Cancer
3.
Asymptomatic Brain Metastases in EGFR-Mutant NSCLC
4.
Mapping lifelong chronic health risks for childhood cancer survivors
5.
Adding Chemo to Osimertinib Doubles PFS in Advanced NSCLC
1.
Respiratory Ramifications of Systemic Disease: A Comprehensive Review
2.
Revolutionizing Lung Cancer Treatment: Exploring the Benefits of Wedge Resection Surgery
3.
Trends in Incidence, Care, and Surgery for Medullary Thyroid Cancer: A Review
4.
Cancer Care Advances: Metformin, Digital Tools, and Artificial Renal Support
5.
Molecular Mechanisms, Clinical Efficacy, and Stem Cell Therapy Integration in Leukemia Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions
2.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
3.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
5.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation